Working... Menu
Trial record 1 of 3 for:    HAMLET | Germany
Previous Study | Return to List | Next Study

Haploidentical Donor vs mMUD in Hematological Malignancies (HAMLET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03275636
Recruitment Status : Recruiting
First Posted : September 7, 2017
Last Update Posted : August 22, 2018
Information provided by (Responsible Party):
DKMS gemeinnützige GmbH

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 2022
  Estimated Study Completion Date : October 2023